期刊文献+

格列齐特对老年糖尿病患者冠状动脉血流储备变化的初步观察

The effects of treatment with gliclazide on coronary flow reserve in elderly diabetic
原文传递
导出
摘要 目的 观察老年糖尿病患者冠状动脉血流储备 (coronaryflowreserve ,CFR)的变化及格列齐特治疗对糖尿病患者CFR的影响。 方法 选取 2 5例 2型糖尿病患者 ,将格列齐特治疗前患者血糖、糖化血红蛋白A1c、血脂、内皮素 1水平及CFR(应用彩色多普勒超声仪检测 )结果与 2 8例健康老年人作对照 ,并将治疗前、后的各项指标进行比较。 结果 格列齐特治疗 6个月后 ,患者的空腹血糖、早餐后 2h血糖、糖化血红蛋白A1c及内皮素 1水平较治疗前显著下降 (均为P <0 0 1) ,甘油三酯水平下降 (P <0 0 5 ) ,CFR从治疗前的 2 31± 0 4 9上升到 3 2 9± 0 4 2 (P <0 0 1)。结论 应用格列齐特治疗可改善老年糖尿病患者的CFR。 Objective In order to evaluate the coronary flow reserve (CFR) in elderly diabetic and the effects of therapy with gliclazide on CFR in these patients. Methods Twenty-five elderly diabetic and 28 healthy elderly subjects were studied. Both the levels of fast blood glucose (FBG), blood glucose 2 hours after breakfast (P2hBG), glycosylation hemoglobin A1c(HbA1c), serum total cholesterol (TC), low density lipid cholesterol (LDL-C), triglyceride (TG), endothelin-1 (ET-1), and CFR in control group were compared with those in elderly diabetic. Furthermore, comparison was made between the corresponding data in elderly diabetic pre- and post- treatment with gliclazide. Results After gliclazide treatment in elderly diabetic for 6 months, the levels of FBG, P2hBG, HbA1c, and ET-1 were obviously decreased (P<0.01, respectively), also TG were reduced (P<0.05) while the CFR were increased from 2.31±0.49 to 3.29±0.42(P<0.01). Conclusions The CFR in elderly diabetic is significantly decreased and could be effectively improved by gliclazide.
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2003年第10期581-583,共3页 Chinese Journal of Geriatrics
基金 湖北省"九五"重点攻关课题资助 (95 2P110 1)
关键词 格列齐特 糖尿病 冠状动脉血流储备 血流速度 老年人 Coronary circulation Blood flow velocity Diabetes mellitus,non-insulin-dependent Gliclazide
  • 相关文献

参考文献8

  • 1张奇,沈卫峰,张建盛,张大东,张瑞岩,吕安康,张宪,郑爱芳.早期糖代谢异常对冠状动脉血流储备的影响[J].中华心血管病杂志,2001,29(10):577-579. 被引量:11
  • 2Pitkanen OP, Nauutila P, Raitakari OT, et al. Coronary flow reserve is reduced in young men with IDDM. Diabetes, 1998,47:248-254.
  • 3Desfaits AC, Serri O, Renier G. Normalization of plasma lipid periods, monocyte adhesion, and tumor necrosis factor-alpha production in NIDDM patients after gliclazide treatment. Diabetes Care, 1998, 21: 487-493.
  • 4Srivastava. High glucose-induced activation of protein kinase signaling pathways in vascular smooth muscle cells: a potential role in the pathogenesis of vascular dysfunction in diabetes. Int J Mol Med, 2002, 9:85-89.
  • 5Hattori Y, Suzuki M, Hattori S, et al. Vascular smooth muscle cell activation by glycated albumin (Amadori adducts ).Hypertension, 2002, 39 : 22-28.
  • 6Vallejo O, Angulo J, Peiro C, et al. Highly glycated oxyhaemoglobin impairs nitric oxide relations in human mesenteric microvessels. Diabetologia, 2000, 4:3 : 110:3-1107.
  • 7Desfaits AC, Serri O, Renier G. Gliclazide reduces the induction of human monocyte adhesion to endothelial cells by glycated albumin. Diabetes Obes Metab, 19990 1:113-120.
  • 8Renier G, Desfaits AC, Serri O. Gliclazide decreases low-density lipoprotein oxidation and monocyte adhesion to endothelium. Metabolism, 2000, 49 : 17-22.

二级参考文献2

  • 1King H,Diabetes Care,1998年,21卷,1414页
  • 2Timimi F K,J Am Coll Cardiol,1998年,31卷,552页

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部